Page 541 - medicina-integrativa_compress

546 PARTE II, SECCIÓN 8 TRASTORNOS AUTOINMUNITARIOS

30. Greenberg GR, Fleming CR, Jeejeebhoy KN, et al: Controlled trial 57. Barnes RMR, Allan S, Taylor-Robinson CH, et al: Serum antibodies
of bowel rest and nutritional support in the management of reactive with Saccharomyces cerevisiae in inflammatory bowel disease:
Crohn’s disease. Gut 29:1309-1315, 1988. Is IgA antibody a marker for Crohn’s disease? Int Arch Allergy Appl
31. Johnson T, Macdonald S, Hill SM, et al: Treatment of active Crohn’s Immunol 92:9-15, 1990.
disease in children using partial enteral nutrition with liquid 58. Konrad A, Rutten C, Flogerzi B, et al: Immune sensitization to yeast
formula: A randomised controlled trial. Gut 55:356-361, 2006. antigens in ASCA-positive patients with Crohn’s disease. Inflamm
~
32. Gonzalez-Huix F, de Leon R, Fernandez-Banares F, et al: Polymeric Bowel Dis 10:97-105, 2004.
enteral diets as primary treatment of active Crohn’s disease: 59. Barclay GR, McKenzie H, Pennington J, et al: The effect of dietary
A prospective steroid-controlled trial. Gut 34:778-782, 1993. yeast on the activity of stable chronic Crohn’s disease. Scand J
33. Middleton SJ, Rucker JT, Kirby GA, et al: Long-chain triglycerides Gastroenterol 27:196-200, 1992.
reduce the efficacy of enteral feeds in patients with active Crohn’s 60. Jowett SL, Seal CJ, Phillips E, et al: Dietary beliefs of people with
disease. Clin Nutr 14:229-236, 1995. ulcerative colitis and their effect on relapse and nutrient intake.
34. Bamba T, Shimoyama T, Sasaki M, et al: Dietary fat attenuates the Clin Nutr 23:161-170, 2004.
benefits of an elemental diet in active Crohn’s disease: A randomized, 61. Canbdy S, Borok G, Wright JP et al: The value of an elimination diet
controlled trial. Eur J Gastroenterol Hepatol 15:151-157, 2003. in the management of patients with ulcerative colitis. S Afr Med J
35. Sakurai T, Matsui T, Yal T, et al: Short-term efficacy of enteral 85:1176-1179, 1995.
nutrition in the treatment of active Crohn’s disease: A randomized- 62. Wright R, Truelove SC: A controlled trial of various diets in
controlled trial comparing nutrient formulas. JPEN J Parenter ulcerative colitis. BMJ 2:138-141, 1965.
Enteral Nutr 26:98-103, 2002. 63. Mason JB: Folate, colitis, dysplasia, and cancer. Nutr Rev 47:
36. Knight C, El-Matary W, Spray C, Sandhu BK: Long-term outcome 314-317, 1989.
of nutritional therapy in paediatric Crohn’s disease. Clin Nutr 64. Chowers Y, Sela BA, Holland R, et al: Increased levels of
24:775-779, 2005. homocysteine in patients with Crohn’s disease are related to folate
37. Afzal NA, Davies S, Paintin M, et al: Colonic Crohn’s disease in levels. Am J Gastroenterol 95:3498-3502, 2000.
children does not respond well to treatment with enteral nutrition 65. Den Heijer M, Koster T, Blom HJ, et al: Hyperhomocysteinemia as
if the ileum is not involved. Dig Dis Sci 50:1471-1475, 2005. a risk factor for deep-vein thrombosis. N Engl J Med 334:759-762,
38. Ikeuchi H, Yamamura T, Nakano H, et al: Efficacy of nutritional 1996.
therapy for perforating and non-perforating Crohn’s disease. 66. Lashner BA, Provencher KS, Seidner DL, et al: Effect of folate
Hepatogastroenterology 51:1050-1052, 2004. supplementation on the incidence of dysplasia and cancer in chronic
39. Nieves R, Jackson RT: Specific carbohydrate diet in treatment ulcerative colitis: A case-control study. Gastroenterology 97:255-259,
of inflammatory bowel disease. Tenn Med 97:407, 2004. 1989.
40. Gottschall E: Breaking the Vicious Cycle. Kirkton, Ontario, Kirkton 67. Diculescu M, Ciocirlan M, Ciocirlan M, et al: Folic acid and
Press, 1994. sulfasalazine for colorectal carcinoma chemoprevention in patients
41. Matsui T, Mitsuo I, Fujishima M, et al: Increased sugar with ulcerative colitis: The old and new evidence. Rom J
consumption in Japanese patients with Crohn’s disease. Gastroenterol 12:283-86, 2003.
Gastroenterol Jpn 25:271, 1990. 68. Logan EC, Williamson LM, Ryrie DR: Sulphasalazine associated
42. Martini GA, Brandes JW: Increased consumption of refined pancytopenia may be caused by acute folate deficiency. Gut 27:
carbohydrates in patients with Crohn’s disease. Klin Wochens 868-872, 1986.
54:367-371, 1976. 69. Beeken WL: Remediable defects in Crohn disease. Arch Intern Med
43. Thurnton JR, Emmett PM, Heaton KW: Diet and Crohn’s disease: 135:686-690, 1975.
Characteristics of the preillness diet. BMJ 2:762-764, 1979. 70. Romagnuolo J, Fedorak RN, Dias VC: Hyperhomocysteinemia
44. Mayberry JF, Rhodfes J, Newcombe RC: Increased sugar and inflammatory bowel disease: Prevalence and predictors in a
consumption in Crohn’s disease. Digestion 20:323-326, 1980. cross-sectional study. Am J Gastroenterol 96:2143-2149, 2001.
45. Heaton KW, Thornton JR, Emmett PM: Treatment of Crohn’s 71. Penix LP: Ischemic strokes secondary to vitamin B 12 deficiency-
disease with an unrefined-carbohydrate, fiber-rich diet. BMJ 2: induced hyperhomocystinemia. Neurology 51:622-624, 1998.
764-766, 1979. 72. Abe S, Wakabayashi Y, Hirose S: [Megaloblastic anemia associated
46. Galland L: Nutritional therapy for Crohn’s disease: Disease with diffuse intestinal Crohn’s disease] Rinsho Ketsueki 30:51-55,
modifying and medication sparing. Altern Ther 5:94-95, 1999. 1989.
47. Inan MS, Rasoulpour RJ, Yin L, et al: The luminal short-chain fatty 73. Saibeni S, Cattaneo M, Vecchi M, et al: Low vitamin B 6 plasma
acid butyrate modulates NF-kappaB activity in a human colonic levels, a risk factor for thrombosis, in inflammatory bowel disease:
epithelial cell line. Gastroenterology 118:724-734, 2000. Role of inflammation and correlation with acute phase reactants.
48. Vernia P, Annese V, Bresci G, et al; Gruppo Italiano per lo Studio Am J Gastroenterol 98:112-117, 2003.
del Colon and del Retto: Topical butyrate improves efficacy of 5- 74. Younes-Mhenni S, Derex L, Berruyer M, et al: Large-artery stroke in
ASA in refractory distal ulcerative colitis: Results of a multicentre a young patient with Crohn’s disease: Role of vitamin B 6 deficiency-
trial. Eur J Clin Invest 33:244-248, 2003. induced hyperhomocysteinemia. J Neurol Sci 221:113-115, 2004.
49. Roediger WE, Duncan A, Kapaniris O, Millard S: Reducing sulfur 75. Fernandez-Banares F, Abad-Lacruz A, Xiol X, et al: Vitamin status
compounds of the colon impair colonocyte nutrition: Implications in patients with inflammatory bowel disease. Am J Gastroenterol
for ulcerative colitis. Gastroenterology 104:802-809, 1993. 84:744-748, 1989.
50. Roediger WE, Moore J, Babidge W: Colonic sulfide in pathogenesis 76. Aghdassi E, Wendland E, Steinhard H, et al: Antioxidant vitamin
and treatment of ulcerative colitis. Dig Dis Sci 42:1571-1579, 1997. supplementation in Crohn’s disease decreases oxidative stress:
51. Magee EA, Richardson CJ, Hughes R, Cummings JH: Contribution A randomized controlled trial. Am J Gastroenterol 98:348-353, 2003.
of dietary protein to sulfide production in the large intestine: An in 77. Rumi G Jr, Szabo I, Vincze A, et al: Decrease of serum carotenoids
vitro and a controlled feeding study in humans. Am J Clin Nutr in Crohn’s disease. J Physiol Paris 94:159-161, 2000.
72:1488-1494, 2000. 78. Bousvaros A, Zurakowski D, Duggan C, et al: Vitamins A and E
52. Jowett SL, Seal CJ, Pearce MS, et al: Influence of dietary factors on serum levels in children and young adults with inflammatory bowel
the clinical course of ulcerative colitis: A prospective cohort study. disease: Effect of disease activity. J Pediatr Gastroenterol Nutr
Gut 53:1479-1484, 2004. 26:129-135, 1998.
53. Roediger WE: Decreased sulphur aminoacid intake in ulcerative 79. Reimund JM, Arondel Y, Escalin G, et al: Immune activation and
colitis. Lancet 351:1555, 1998. nutritional status in adult Crohn’s disease patients. Dig Liver Dis
54. Ballegaard M, Bjergstrom A, Brondum S, et al: Self-reported food 37:424-431, 2005.
intolerance in chronic inflammatory bowel disease. Scand J 80. Sampietro GM, Cristaldi M, Cervato G, et al: Oxidative stress,
Gastroenterol 32:569-571, 1997. vitamin A and vitamin E behaviour in patients submitted to
55. Riordan AM, Hunter JO, Cowan RE, et al: Treatment of active conservative surgery for complicated Crohn’s disease. Dig Liver Dis
Crohn’s disease by exclusion diet: East Anglican multicentre 34:696-701, 2002.
controlled trial. Lancet 342:1131-1134, 1993. 81. Janczewska I, Bartnik W, Butruk E, et al: Metabolism of vitamin A
56. Alun Jones V, Workman E, Freeman AH: Crohn’s disease: in inflammatory bowel disease. Hepatogastroenterology 38:391-395,
Maintenance of remission by diet. Lancet 2:177-180, 1985. 1991.